Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma (Q40564050)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma |
scientific article published on April 2004 |
Statements
1 reference
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma (English)
1 reference
Rhona Stein
1 reference
Zhengxing Qu
1 reference
Susan Chen
1 reference
Adriane Rosario
1 reference
Victoria Shi
1 reference
Marianne Hayes
1 reference
Ivan D Horak
1 reference
Hans J Hansen
1 reference
David M Goldenberg
1 reference
1 April 2004
1 reference
1 reference
Identifiers
1 reference